Lynne Soughley

Health Technology

Profile

Lynne Soughley is Director of Clinical Development for Argolyn Bioscience, Inc. Most recently, she worked at Parexel GmbH.
Prior to joining Parexel, she was a Consultant at Sepracor, Inc. and a Clinical Operations Consultant at Adnexus Therapeutics, Inc. She was a Senior Project Manager of Quintiles International and Bristol Myers Squibb Co. Previously, she worked at eNOS Pharmaceuticals.
She has 20 years of experience in the health care industry with 10 years of experience in drug development and clinical research.
Ms. Soughley holds a BSc degree in Biology.

Former positions of Lynne Soughley

Companies	Position	End
Argolyn Bioscience, Inc. Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC.	Corporate Officer/Principal	26/11/2009
Enos Pharmaceuticals, Inc. Enos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Palmetto Pharmaceuticals LLC, Enos Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in Lexington, MA. The company was founded by James R. McNab, Alexander M. Klibanov.	Corporate Officer/Principal	-
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	-
Adnexus Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA.	Corporate Officer/Principal	-
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA.	Corporate Officer/Principal	-

See the detail of Lynne Soughley's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies